Henan Haitian Biotechnology Co Ltd

A GMP-certified veterinary drug manufacturer committed to long-term win-win partnership.

Henan Haitian Biotechnology Co Ltd
  • Home
  • About
  • Products
  • Contact
  • News
  • Home
  • About
  • Products
  • Contact
  • News
  • Meloxicam for newborn calves: dose at birth, not surgery

    Meloxicam for newborn calves is a postnatal adaptation treatment, not a surgical analgesic. In a 151-calf placebo-controlled trial, one subcutaneous dose of 0.5 mg/kg given within minutes of delivery produced higher vitality scores at 24 and 48 hours, with the gain concentrated in calves born with obstetric assistance. It did not correct perinatal acidosis. Why meloxicam is filed under the wrong job Most farms keep meloxicam wherever the disbudding iron lives. Castration, dehorning, lameness, anything that happens in a chute: the drug goes on the list, and in many markets the label reads the same way. That placement is a habit, not a pharmacology. Parturition is an inflammatory event in…

    read more

    You May Also Like

    Veterinary Oxytetracycline: A Comprehensive Guide for Pig Clinical Applications

    October 7, 2025

    FDA’s Approval of Faunamor: A Breakthrough for Ornamental Fish Health

    April 11, 2025

    Why Measuring Butyrylcholinesterase Might Not Help in Organophosphorus Poisoning Treatment

    March 26, 2026
2026 Henan Haitian Biotechnology Co., Ltd. ©.
Ashe Theme by WP Royal.